Condensed Consolidated Statements of Cash Flows (Unaudied) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (4,073,307)	$ (1,874,382)
Adjustments to reconcile net loss to net cash used in operating activities
Compensation cost for stock options granted	275,833	215,139
Depreciation and amortization	13,983	7,864
Change in fair value of stock-based compensation liability	1,741,919
Changes in operating assets and liabilities:
Prepaid expenses	(325,635)	(244,723)
Research and development tax rebate receivable	280,242	(37,595)
Other assets	2,985	51,512
Accounts payable	110,642	(166,554)
Payroll liabilities	(43,312)	(428,440)
Accrued expenses	(102,230)	82,508
Other current liabilities	(30,076)	7,789
Net cash used in operating activities	(2,148,956)	(2,386,882)
CASH FLOWS FROM INVESTING ACTIVITY
Purchase of furniture and equipment		(51,068)
Net cash used in investing activities		(51,068)
CASH FLOWS FROM FINANCING ACTIVITY
Proceeds from exercise of warrants	11,336,710
Net cash provided by financing activities	11,336,710
NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	9,187,754	(2,437,950)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING BALANCE	10,490,493	7,272,469
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING BALANCE	19,678,247	4,834,519
SUPPLEMENTAL DISCLOSURES
Cash and cash equivalents	19,568,247	4,779,519
Restricted cash	110,000	55,000
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, ENDING BALANCE	19,678,247	4,834,519
NONCASH INVESTING AND FINANCING ACTIVITIES
Reclassification of stock-based liability awards to equity upon cancellation	3,151,944
Amortization of commitment shares		$ 19,852